BioCentury
ARTICLE | Company News

Vanda management update

April 22, 2013 7:00 AM UTC

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), Washington, D.C. Business: Neurology Transitioned: Paolo Baroldi to SVP and CMO from acting CMO ...